Blue Cross in-house development capabilities have contributed immensely to it's growing product range and technology development, especially with regard to dispersible and other forms of tablets. Blue Cross is recognized as the pioneers in dispersible, mouth-dissolving and sublingual tablet technologies in India.
The R&D division is currently focusing on the development of Novel Drug Delivery Systems (NDDS) aimed at providing solutions that effectively satisfy unmet medical needs. The goal is to design S.R./C.R. systems, which will reduce the frequency of dosage and increase the effectiveness of the drug by localization at the site of action.